ARCHIVES

In Brief: Fischinger, SAIC Win $400 Million Contract

This article is from The Cancer Letter archive.

Vol. 21 No. 09 | March 3, 1995

Download PDF Visit The Full Archive

Related Articles

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005

New Approaches To Therapy For Difficult Cancers Presented

June 29, 2007